Physician profile
Gregory Thompson
NPI 1063410702
$1,570.90
in general payments reported to CMS, 2019-2025
23 companies · $21.68 in 2025
The $21.68 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $470 · 2021: $18.86 · 2022: $44.10 · 2023: $53.75 · 2025: $21.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $262.50 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $245.52 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $240.39 | 2019-2020 | |
| Boston Scientific Corporation | $152.96 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $98.28 | 2020 | |
| Pfizer INC. | $83.10 | 2019 | |
| Janssen Biotech, INC. | $83.05 | 2019-2020 | |
| Abbvie INC. | $75.33 | 2019-2025 | Botox |
| Novus Surgical Consultants | $31.86 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $30.14 | 2022 | |
| Myriad Genetic Laboratories, INC. | $29.55 | 2020 | |
| Endo Pharmaceuticals INC. | $26.40 | 2019 | |
| Axonics, INC. | $25.40 | 2020 | |
| Shire North American Group INC | $24.50 | 2019 | |
| Acerus Pharmaceuticals Corporation | $24.15 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $23.67 | 2019 | |
| 180 Medical, INC. | $17.64 | 2020 | |
| Zyla Life Sciences, INC. | $17.49 | 2020 | |
| Amgen INC. | $17.22 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $17.20 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $16.91 | 2020 | |
| Merck Sharp & Dohme LLC | $16.72 | 2020 | |
| Antares Pharma, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.